Rho Presenting During the 14th Clinical Trials Innovation Programme (CTIP) in San Francisco

WHAT: Rho, a full-service contract research organization (CRO that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will highlight its clinical trial expertise during the 14^th Clinical Trials Innovation Programme (CTIP) 2019, taking place on October 22-23 in San Francisco, California.

Dr. Yael Symes, an integrated product development associate at Rho, will be presenting during the conference, incorporating her extensive experience including regulatory strategy and contributions as an author to regulatory submissions including INDs and NDAs. Dr. Symes has a public health background, with expertise in health behavior, patient advocacy, cancer survivorship, and social determinants of health. Her talk, “Improving Diversity in Clinical Research: The Ethical, Scientific, and Financial Impact” will discuss who is currently participating in clinical trials by race and ethnicity and explore why racial and ethnic diversity in clinical trials is important for ethical, scientific, and financial reasons. The presentation will recommend specific steps that sponsors, CROs, investigators, and sites can take to increase diversity in clinical trials.

To learn more, please stop by Rho’s booth during the conference.

WHO: Rho expert at 14^th CTIP:

• Dr. Yael Symes, integrated product development associate, Rho

WHEN: October 22-23, 2019

WHERE: The Westin San Francisco Airport

1 Old Bayshore Hwy

Millbrae, CA 94030

DETAILS: For media inquiries, please contact Kelly Maicon at Largemouth Communications, 919.741.9784, kmaicon@largemouthpr.com.

ABOUT: Rho, a privately held, contract research organization (CRO) located in Research Triangle Park, NC, provides a full range of clinical research services across the entire drug development process. For more than 35 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Facebook, LinkedIn and Twitter.